GDAP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.064000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.621800E-01
Normal-vs-Stage2
7.291000E-01
Normal-vs-Stage3
1.033770E-01
Normal-vs-Stage4
1.710180E-01
Stage1-vs-Stage2
4.987000E-01
Stage1-vs-Stage3
4.375200E-01
Stage1-vs-Stage4
1.661960E-01
Stage2-vs-Stage3
2.358000E-01
Stage2-vs-Stage4
4.378200E-01
Stage3-vs-Stage4
2.629600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.254000E-01
Normal-vs-AfricanAmerican
5.135000E-01
Normal-vs-Asian
8.768200E-01
Caucasian-vs-AfricanAmerican
7.062000E-01
Caucasian-vs-Asian
8.450400E-01
AfricanAmerican-vs-Asian
5.542200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.530400E-01
Normal-vs-Female
7.349000E-01
Male-vs-Female
7.444400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.501600E-01
Normal-vs-Age(41-60Yrs)
6.667800E-02
Normal-vs-Age(61-80Yrs)
9.385000E-01
Normal-vs-Age(81-100Yrs)
7.560800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.909800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.250200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.308000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.240200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.806400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.300000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.755000E-01
Normal-vs-Daily Drinker
9.479800E-01
Normal-vs-Weekly Drinker
5.076200E-01
Normal-vs-Occasional Drinker
6.260200E-01
Normal-vs-Social Drinker
9.962800E-01
Non Drinker-vs-Daily Drinker
9.155400E-01
Non Drinker-vs-Weekly Drinker
4.904000E-01
Non Drinker-vs-Occasional Drinker
3.236200E-01
Non Drinker-vs-Social Drinker
9.620800E-01
Daily Drinker-vs-Weekly Drinker
4.791200E-01
Daily Drinker-vs-Occasional Drinker
3.963000E-01
Daily Drinker-vs-Social Drinker
9.040400E-01
Weekly Drinker-vs-Occasional Drinker
7.122800E-01
Weekly Drinker-vs-Social Drinker
5.095000E-01
Occasional Drinker-vs-Social Drinker
4.229800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.998600E-01
Normal-vs-Grade 2
2.970400E-01
Normal-vs-Grade 3
3.736200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.197100E-03
Grade 1-vs-Grade 3
2.475400E-03
Grade 1-vs-Grade 4
3.998600E-01
Grade 2-vs-Grade 3
3.502800E-01
Grade 2-vs-Grade 4
2.970400E-01
Grade 3-vs-Grade 4
3.736200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.595000E-01
Normal-vs-NonDiabetic
8.288600E-01
Diabetic-vs-NonDiabetic
1.543360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.795400E-01
Normal-vs-NoPancreatitis
8.692200E-01
Pancreatitis-vs-NoPancreatitis
4.979400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.047000E-01
Normal-vs-N1
6.904200E-01
N0-vs-N1
1.001530E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.696490E-02
Normal-vs-TP53-NonMutant
6.960200E-01
TP53-Mutant-vs-TP53-NonMutant
9.047200E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
